Infect Chemother.
2022 Jun;54(2):353-359. 10.3947/ic.2022.0069.
Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea
- Kwak MY
1 - Jo EY2
- Chin B3
- Park SE1
- Yim J1,4
- Lee JE1
- Jo KE1
- Kim YS5
- Lee JE6
- Yoon YK7
- Seo YB8
- Jeong SJ9
- Kang YM10
- Joo EJ11
- Yoon JH12
- Kim SB13
- Kim GY3
- Kim MK3
- Affiliations
-
- 1Center for Public Health, National Medical Center, Seoul, Korea
- 2Chungcheongnam-do Seosan Medical Center, Seosan, Korea
- 3Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul, Korea
- 4Graduate School of Urban Public Health, University of Seoul, Seoul, Korea
- 5Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea
- 6Division of Infectious Diseases, Department of Internal Medicine, Pusan National University Hospital, Busan, Korea
- 7Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- 8Division of Infectious Diseases, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea
- 9Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
- 10Division of Infectious Diseases, Department of Internal Medicine, Myongji Hospital, Goyang, Korea
- 11Division of Infectious Diseases, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
- 12Department of Urology, National Medical Center, Seoul, Korea
- 13Division of Infectious Diseases, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea
- KMID: 2531024
- DOI: http://doi.org/10.3947/ic.2022.0069
Abstract
- Despite the coronavirus disease 2019 (COVID-19) vaccination roll-out, variant-related outbreaks have occurred repeatedly in Korea. Although public hospitals played a major role in COVID-19 patients’ care, difficulty incorporating evolving COVID-19 treatment guidelines called for a clinical pathway (CP). Eighteen public hospitals volunteered, and a professional review board was created. CPs were formulated containing inclusion/exclusion criteria, application flow charts, and standardized order sets. After CP roll-out, key parameters improved, such as increased patient/staff five-point satisfaction scores (0.41/0.57) and decreased hospital stays (1.78 days)/medical expenses (17.5%). The CPs were updated consistently after roll-out as new therapeutics drugs were introduced and quarantine policies changed.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Coronavirus Disease 2019 (COVID-19): Pandemic and the Challenge of Public Health
- Advice on Standardized Diagnosis and Treatment for Spinal Diseases during the Coronavirus Disease 2019 Pandemic
- Clinical and Epidemiological Characteristics of Coronavirus Disease 2019 in the Early Stage of Outbreak
- Individualizing dialysis dose under certain circumstances during the Severe Acute Respiratory Syndrome Coronavirus-2 (coronavirus disease 2019) pandemic: a perspective
- Changes in the Hospital Standardized Mortality Ratio Before and During the COVID-19 Pandemic: A Disaggregated Analysis by Region and Hospital Type in Korea
